Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jonathan R CarapetisG Hogg

Abstract

We conducted a 12-year review of all cases of group A streptococcal (GAS) bacteremia that were seen at Royal Children's Hospital in Melbourne, Australia, from 1982 through 1993. Forty-two cases were identified. There was a trend towards increased incidence of infections, as well as a clear increase in their severity, during the study period; more previously healthy children were affected during the last 6 years of the study (80% of cases) than during the first 6 years (47% of cases), and more complications occurred during the latter period than during the former (40% vs. 20%, respectively, with an 88% complication rate over the last 12 months). Seventy-four GAS isolates (41 invasive, 23 noninvasive, and 10 indeterminate) were analyzed. An M type 1 clone that was positive for the pyrogenic exotoxin A gene (speA) and that has been found to cause invasive disease in the Northern Hemisphere was most frequent among invasive isolates. Molecular typing also identified a genetically distinct strain that was virulent, mucoid, and M nontypable. Invasive GAS disease in Melbourne has become increasingly aggressive. Newer typing methods should be used in conjunction with traditional serotyping in order to maintain epidemiological surveillan...Continue Reading

Citations

Jun 7, 2005·Trends in Microbiology·Mark J WalkerMarie Ranson
Jul 9, 2010·Epidemiology and Infection·B D WhiteheadC Nourse
Aug 31, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David J McMillanG S Chhatwal
Jun 4, 2008·The Pediatric Infectious Disease Journal·Jesus AgueroLuis Martinez-Martinez
Feb 11, 2010·Pediatric Emergency Care·Ariel A Salas
Apr 21, 2007·Journal of Paediatrics and Child Health·Andrew C SteerJonathan R Carapetis
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Dec 17, 2008·Journal of Clinical Microbiology·Tuula SiljanderJaana Vuopio-Varkila
Oct 18, 2000·The Journal of Clinical Investigation·C CywesM R Wessels
Nov 12, 2013·Trends in Molecular Medicine·Robert J CommonsNigel Curtis
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·K E StockbauerJ M Musser
Apr 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Waleed NasserJames M Musser
Oct 14, 2014·The Journal of Infection·Claire S WaddingtonJonathan R Carapetis
Mar 1, 2008·Expert Opinion on Medical Diagnostics·Andrew C SteerJonathan R Carapetis
Jul 9, 2013·Critical Care Clinics·Donald E Low
Sep 25, 2004·Molecular Microbiology·Monika MangoldEmmanuelle Charpentier
Jun 10, 2014·Journal of Paediatrics and Child Health·Anna LithgowPierre Robert Smeesters
Oct 31, 2014·Tropical Medicine & International Health : TM & IH·R J GearJ S Davis
Jun 4, 2014·International Reviews of Immunology·Madeleine W Cunningham
Nov 21, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Milena Soares SantosJoice Neves Reis
Nov 16, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P HarrisR Norton
Feb 18, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B J M VlaminckxJ F P Schellekens
Feb 22, 2005·Annals of Tropical Paediatrics·Ergin CiftçiUlker Doğru
Jun 16, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Josette RaymondAnne Bouvet
Apr 8, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·David ErmertAnna M Blom
Aug 24, 2000·The Australasian Journal of Dermatology·B J Currie, J R Carapetis
Nov 13, 2015·Journal of Clinical Microbiology·Karen RudolphThomas Hennessy
Jun 13, 2012·Drugs·Andrew C SteerJonathan R Carapetis
Jun 25, 2014·Journal of Paediatrics and Child Health·Bianca MiddletonJonathan Carapetis
May 12, 2015·The Pediatric Infectious Disease Journal·Helen S MarshallIngrid L Scully
Jan 1, 1997·Scandinavian Journal of Infectious Diseases·A S Breathnach, S J Eykyn
Oct 7, 2015·The Pediatric Infectious Disease Journal·Terhi TapiainenMatti Uhari
Jun 6, 2007·The Medical Journal of Australia·Kerry-Ann F O'GradyJonathan R Carapetis
Aug 1, 1997·FEMS Immunology and Medical Microbiology·R Krause

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.